Linda Burkly
Chief Tech/Sci/R&D Officer at EDITAS MEDICINE, INC.
Net worth: - $ as of 2024-05-30
Profile
Linda C.
Burkly is currently the Chief Scientific Officer & Executive VP at Editas Medicine, Inc. Prior to her current position, she worked at Biogen, Inc. as the Vice President & Senior Distinguished Investigator from 2014 to 2022.
Burkly received her undergraduate degree from Fairfield University and her doctorate from Tufts University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
EDITAS MEDICINE, INC.
-.--% | 2024-04-01 | 0 ( -.--% ) | - $ | 2024-05-30 |
Linda Burkly active positions
Companies | Position | Start |
---|---|---|
EDITAS MEDICINE, INC. | Chief Tech/Sci/R&D Officer | 2023-07-23 |
Former positions of Linda Burkly
Companies | Position | End |
---|---|---|
BIOGEN INC. | Corporate Officer/Principal | 2021-12-31 |
Training of Linda Burkly
Tufts University | Doctorate Degree |
Fairfield University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
EDITAS MEDICINE, INC. | Health Technology |
BIOGEN INC. | Health Technology |
- Stock Market
- Insiders
- Linda Burkly